Abstract:Background Public resources of chemical compound are in a rapid growth both in quantity and the types of data-representation. To comprehensively understand the relationship between the intrinsic features of chemical compounds and protein targets is an essential task to evaluate potential protein-binding function for virtual drug screening. In previous studies, correlations were proposed between bioactivity profiles and target networks, especially when chemical structures were similar. With the lack of effective quantitative methods to uncover such correlation, it is demanding and necessary for us to integrate the information from multiple data sources to produce an comprehensive assessment of the similarity between small molecules, as well as quantitatively uncover the relationship between compounds and their targets by such integrated schema. Results In this study a multi-view based clustering algorithm was introduced to quantitatively integrate compound similarity from both bioactivity profiles and structural fingerprints. Firstly, a hierarchy clustering was performed with the fused similarity on 37 compounds curated from PubChem. Compared to clustering in a single view, the overall common target number within fused classes has been improved by using the integrated similarity, which indicated that the present multi-view based clustering is more efficient by successfully identifying clusters with its members sharing more number of common targets. Analysis in certain classes reveals that mutual complement of the two views for compound description helps to discover missing similar compound when only single view was applied. Then, a large-scale drug virtual screen was performed on 1267 compounds curated from Connectivity Map (CMap) dataset based on the fused similarity, which obtained a better ranking result compared to that of single-view. These comprehensive tests indicated that by combining different data representations; an improved assessment of target-specific compound similarity can be achieved. Conclusions Our study presented an efficient, extendable and quantitative computational model for integration of different compound representations, and expected to provide new clues to improve the virtual drug screening from various pharmacological properties. Scripts, supplementary materials and data used in this study are publicly available at http://lifecenter.sgst.cn/fusion/ .

CACTI: an in silico chemical analysis tool through the integration of chemogenomic data and clustering analysis

drug-target prediction tool through the integration of chemogenomic data and clustering analysis

TargetHunter: an in Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database

Quantitatively integrating molecular structure and bioactivity profile evidence into drug-target relationship analysis

Development of Structure-Based Pharmacophore to Target the Β-Catenin-tcf Protein–protein Interaction

In-silico Target Prediction by Ensemble Chemogenomic Model Based on Multi-Scale Information of Chemical Structures and Protein Sequences.

Combining CRISPRi and metabolomics for functional annotation of compound libraries

CytoCopasi: a chemical systems biology target and drug discovery visual data analytics platform

Sdtnbi: an Integrated Network and Chemoinformatics Tool for Systematic Prediction of Drug-Target Interactions and Drug Repositioning

Chemical-Protein Interactome and Its Application in Off-Target Identification

Prediction of Chemical-Protein Interactions: Multitarget-Qsar Versus Computational Chemogenomic Methods

Genome-Scale Screening Of Drug-Target Associations Relevant To K-I Using A Chemogenomics Approach

Generating Gene Ontology-Disease Inferences to Explore Mechanisms of Human Disease at the Comparative Toxicogenomics Database

ISiCLE: A molecular collision cross section calculation pipeline for establishing large in silico reference libraries for compound identification

Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification

Computer-aided pattern scoring – A multitarget dataset-driven workflow to predict ligands of orphan targets

Prediction of drug-target interactions for drug repositioning only based on genomic expression similarity

Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis

Chemical Proteomics-based Target Prioritization through a Residue Agnostic Ligandability Assessment Platform

COMET:Combined Matrix for Elucidating Targets

Toward automated biochemotype annotation for large compound libraries